These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 31810863)
1. A Pharmacological Chaperone Therapy for Acute Intermittent Porphyria. Bustad HJ; Toska K; Schmitt C; Vorland M; Skjærven L; Kallio JP; Simonin S; Letteron P; Underhaug J; Sandberg S; Martinez A Mol Ther; 2020 Feb; 28(2):677-689. PubMed ID: 31810863 [TBL] [Abstract][Full Text] [Related]
2. Acute Intermittent Porphyria: An Overview of Therapy Developments and Future Perspectives Focusing on Stabilisation of HMBS and Proteostasis Regulators. Bustad HJ; Kallio JP; Vorland M; Fiorentino V; Sandberg S; Schmitt C; Aarsand AK; Martinez A Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445488 [TBL] [Abstract][Full Text] [Related]
19. Systematically Analyzing the Pathogenic Variations for Acute Intermittent Porphyria. Fu Y; Jia J; Yue L; Yang R; Guo Y; Ni X; Shi T Front Pharmacol; 2019; 10():1018. PubMed ID: 31572191 [TBL] [Abstract][Full Text] [Related]
20. High penetrance of acute intermittent porphyria in a Spanish founder mutation population and CYP2D6 genotype as a susceptibility factor. Barreda-Sánchez M; Buendía-Martínez J; Glover-López G; Carazo-Díaz C; Ballesta-Martínez MJ; López-González V; Sánchez-Soler MJ; Rodriguez-Peña L; Serrano-Antón AT; Gil-Ferrer R; Martínez-Romero MDC; Carbonell-Meseguer P; Guillén-Navarro E Orphanet J Rare Dis; 2019 Feb; 14(1):59. PubMed ID: 30808393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]